Trademark: 79225044
Word

Status
Registered
Status Code
700
Status Date
Tuesday, February 12, 2019
Serial Number
79225044
Registration Number
5671918
Registration Date
Tuesday, February 12, 2019
Mark Type
2000
Filing Date
Wednesday, October 11, 2017
Published for Opposition
Tuesday, November 27, 2018

Trademark Owner History
Ascendis Pharma A-S - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology; pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
45 Licensing of industrial property; legal services
42 Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
The mark consists of a polygon that is divided by a white curved band with the top section being in turquoise and the bottom section in blue.
The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.

Trademark Events
Feb 12, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 24, 2021
New Representative At Ib Received
Oct 28, 2021
New Representative At Ib Received
Jun 21, 2019
Final Decision Transaction Processed By Ib
Jun 4, 2019
Final Disposition Notice Sent To Ib
Jun 4, 2019
Final Disposition Processed
May 12, 2019
Final Disposition Notice Created, To Be Sent To Ib
Feb 12, 2019
Registered-Principal Register
Nov 27, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 27, 2018
Published For Opposition
Nov 24, 2018
Notification Processed By Ib
Nov 16, 2018
Refusal Processed By Ib
Nov 7, 2018
Notification Of Possible Opposition Sent To Ib
Nov 7, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 7, 2018
Notification Of Notice Of Publication E-Mailed
Oct 17, 2018
Approved For Pub - Principal Register
Sep 28, 2018
Teas/Email Correspondence Entered
Sep 27, 2018
Correspondence Received In Law Office
Sep 27, 2018
Teas Response To Office Action Received
Sep 17, 2018
Notification Of Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action Written
Aug 17, 2018
Teas/Email Correspondence Entered
Aug 17, 2018
Correspondence Received In Law Office
Aug 16, 2018
Assigned To Lie
Jul 26, 2018
Teas Response To Office Action Received
Jul 24, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 24, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 16, 2018
Refusal Processed By Ib
Feb 1, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Feb 1, 2018
Refusal Processed By Mpu
Jan 25, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Jan 24, 2018
Non-Final Action Written
Jan 23, 2018
Application Filing Receipt Mailed
Jan 19, 2018
Assigned To Examiner
Jan 19, 2018
New Application Office Supplied Data Entered
Jan 18, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24